These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 23992331)

  • 1. Cellular and molecular background underlying the diversity in therapeutic responses between primary tumours and metastases.
    Romano S; D'Angelillo A; Romano A; Nappo G; Romano MF
    Curr Med Chem; 2014; 21(14):1631-8. PubMed ID: 23992331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contributions of cancer cell metabolism to metastasis.
    Pascual G; Domínguez D; Benitah SA
    Dis Model Mech; 2018 May; 11(8):. PubMed ID: 29739810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-renewal gene tracking to identify tumour-initiating cells associated with metastatic potential.
    Darini CY; Pisani DF; Hofman P; Pedeutour F; Sudaka I; Chomienne C; Dani C; Ladoux A
    Oncogene; 2012 May; 31(19):2438-49. PubMed ID: 21927026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host and tumour factors in cancer metastasis.
    Fidler IJ
    Eur J Clin Invest; 1990 Oct; 20(5):481-6. PubMed ID: 2124977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour-microenvironmental interactions: paths to progression and targets for treatment.
    Box C; Rogers SJ; Mendiola M; Eccles SA
    Semin Cancer Biol; 2010 Jun; 20(3):128-38. PubMed ID: 20599506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the Progression of Bone Metastases to Identify Novel Therapeutic Targets.
    Schmid-Alliana A; Schmid-Antomarchi H; Al-Sahlanee R; Lagadec P; Scimeca JC; Verron E
    Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29300334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasion and metastasis.
    Carr I; Orr FW
    Can Med Assoc J; 1983 May; 128(10):1164-7. PubMed ID: 6340812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells: Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells.
    Ahmed N; Escalona R; Leung D; Chan E; Kannourakis G
    Semin Cancer Biol; 2018 Dec; 53():265-281. PubMed ID: 30317036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic disparity between primary tumours, disseminated tumour cells, and manifest metastasis.
    Stoecklein NH; Klein CA
    Int J Cancer; 2010 Feb; 126(3):589-98. PubMed ID: 19795462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
    Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
    Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saturated and mono-unsaturated lysophosphatidylcholine metabolism in tumour cells: a potential therapeutic target for preventing metastases.
    Raynor A; Jantscheff P; Ross T; Schlesinger M; Wilde M; Haasis S; Dreckmann T; Bendas G; Massing U
    Lipids Health Dis; 2015 Jul; 14():69. PubMed ID: 26162894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy.
    Denekamp J
    Br J Radiol; 1993 Mar; 66(783):181-96. PubMed ID: 7682469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging paradigms in metastasis research.
    Abdul Pari AA; Singhal M; Augustin HG
    J Exp Med; 2021 Jan; 218(1):. PubMed ID: 33601416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression.
    Philip B; Ito K; Moreno-Sánchez R; Ralph SJ
    Carcinogenesis; 2013 Aug; 34(8):1699-707. PubMed ID: 23740838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concepts of metastasis in flux: the stromal progression model.
    Sleeman JP; Christofori G; Fodde R; Collard JG; Berx G; Decraene C; Rüegg C
    Semin Cancer Biol; 2012 Jun; 22(3):174-86. PubMed ID: 22374376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stem-cell origin of metastasis and heterogeneity in solid tumours.
    Tu SM; Lin SH; Logothetis CJ
    Lancet Oncol; 2002 Aug; 3(8):508-13. PubMed ID: 12147437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal dominance of primary tumours by metastatic cells: genetic analysis and biological implications.
    Kerbel RS; Waghorne C; Korczak B; Lagarde A; Breitman ML
    Cancer Surv; 1988; 7(4):597-629. PubMed ID: 3072068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parallel progression of primary tumours and metastases.
    Klein CA
    Nat Rev Cancer; 2009 Apr; 9(4):302-12. PubMed ID: 19308069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression.
    Brabletz T; Jung A; Spaderna S; Hlubek F; Kirchner T
    Nat Rev Cancer; 2005 Sep; 5(9):744-9. PubMed ID: 16148886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis.
    Iqbal W; Alkarim S; AlHejin A; Mukhtar H; Saini KS
    Oncotarget; 2016 Nov; 7(46):76337-76353. PubMed ID: 27486983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.